Folic acid – role in the body, recommendations and clinical significance

1. Cieślik E., Kościej A. Kwas foliowy – występowanie i znaczenie. Probl Hig Epidemiol. 2012; 93(1): 1–7.Search in Google Scholar

2. Bomba–Opoń D, Hirnle L, Kalinka Ji wsp. Suplementacja folianów w okresie przedkoncepcyjnym, w ciąży i połogu. Rekomendacje Polskiego Towarzystwa Ginekologów i Położników. Gin Perinat Prakt. 2017; 2, 5: 210–214.Search in Google Scholar

3. Paul L, Selhub J. Interaction between excess folate and low vitamin B12 status. Mol Aspects Med. 2017; 53: 43–47.10.1016/j.mam.2016.11.004Open DOISearch in Google Scholar

4. National Institutes of Health. Office of Dietary Supplemensts. Folate. Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Folate-HealthProfessional/. Dostęp: 25.02.2019.Search in Google Scholar

5. Kerr SM, Parker SE, Mitchell AA et al. Periconceptional maternal fever, folic acid intake, and the risk for neural tube defects. Ann Epidemiol. 2017: 27(12); 777–782.10.1016/j.annepidem.2017.10.010Open DOISearch in Google Scholar

6. Putta S, Pennell PB. Management of epilepsy during pregnancy: evidence–based strategies. Future Neurol. 2015; 10 (2): 161–176.10.2217/fnl.15.4Search in Google Scholar

7. Viale L, Allotey J, Cheong-See F et al. Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis. Lancet. 2015; 386(10006): 1845–1852.10.1016/S0140-6736(15)00045-8Search in Google Scholar

8. Gooneratne I.K, Wimalaratna M, Ranaweera AKP et al. Contraception advice for women with epilepsy. BMJ. 2017; 357:j2010.10.1136/bmj.j201028495788Search in Google Scholar

9. Van Gool JD, Hirche H, Lax H et al. Folic acid and primary prevention of neural tube defects: A review. Reprod Toxicol. 2018; 80:73–84.10.1016/j.reprotox.2018.05.00429777755Open DOISearch in Google Scholar

10. Turgal M, Gumruk F, Karaagaoglu E et al. Methylenetetrahydrofolate Reductase Polymorphisms and Pregnancy Outcome. Geburtshilfe Frauenheilkde. 2018: 78(09); 871–878.3025824710.1055/a-0664-8237613847230258247Search in Google Scholar

11. Servy EJ, Jacquesson-Fournols L, Cohen M et al.MTHFR isoform carriers. 5-MTHF (5-methyl tetrahydrofolate) vs folic acid: a key to pregnancy outcome: a case series. J Assist Reprod Genet. 2018: 35(8); 1431–1435.10.1007/s10815-018-1225-2608679829882091Search in Google Scholar

12. Whitrow MJ., Moore VM., Rumbold AR. et al. Effect of Supplemental Folic Acid in Pregnancy on Childhood Asthma: A Prospective Birth Cohort Study. Am J Epidemiol. 2009; 170(12): 1486–1493.10.1093/aje/kwp31519880541Search in Google Scholar

13. Trivedi MK., Sharma S., Rifas–Shiman SL. Et al. Folic Acid in Pregnancy and Childhood Asthma: A US Cohort. Clin Pediatr. 2018; 57(4): 421–427.10.1177/0009922817729482582374628884603Open DOISearch in Google Scholar

14. Vereen S., Gebretsadik T., Johnson N. Association Between Maternal 2nd Trimester Plasma Folate Levels and Infant Bronchiolitis. Matern Child Health J. 2018; 23(2): 164–172.10.1007/s10995-018-2610-2633960730027465Search in Google Scholar

15. Imbard A, Benoist JF, Blom H. Neural Tube Defects, Folic Acid and Methylation. Int J Environ Res Public Health. 2013: 10(9); 4352–4389.10.3390/ijerph10094352379952524048206Open DOISearch in Google Scholar

16. Greene NDE, Copp AJ. Neural Tube Defects. Annu Rev Neurosci. 2014: 37(1); 221–242.10.1146/annurev-neuro-062012-170354448647225032496Open DOISearch in Google Scholar

17. Bagłaj M. Wady dysraficzne: wielospecjalistyczne postępowanie. Stowarzyszenie na Rzecz Dzieci z Rzadkimi Chorobami Genetycznymi i Ich Rodzin Wspólnie. http://wspolnie.org/wady-dysraficzne/. Dostęp: 25.02.2019.Search in Google Scholar

18. Liu S, Joseph KS, Luo W et al. Effect of Folic Acid Food Fortification in Canada on Congenital Heart Disease Subtypes Clinical Perspective. Circulation. 2016: 134(9); 647–655.10.1161/CIRCULATIONAHA.116.022126499812627572879Search in Google Scholar

19. Linask KK, Huhta J. Folate protection from congenital heart defects linked with canonical Wnt signaling and epigenetics. Curr Opin Pediatr. 2010: 22(5); 561–566.10.1097/MOP.0b013e32833e2723300428520844350Open DOISearch in Google Scholar

20. Van Beynum IM, Kapusta L, Bakker MK et al. Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry–based case–control study in the northern Netherlands. Eur Heart J. 2009: 31(4); 464–471.10.1093/eurheartj/ehp47919952004Search in Google Scholar

21. Groen in’t Woud S, Renkema KY, Schreuder MF et al. Maternal risk factors involved in specific congenital anomalies of the kidney and urinary tract: A case–control study. Birth Defects Res A Clin Mol Teratol. 2016: 106(7);596–603.10.1002/bdra.2350027040999Search in Google Scholar

22. Canfield MA, Collins JS, Botto LD et al. Changes in the birth prevalence of selected birth defects after grain fortification wiht folic acid in the United States: Findings from a multi-state population–based study. Birth Defects Res A Clin Mol Teratol. 2005: 73(10); 679–689.10.1002/bdra.2021016240378Search in Google Scholar

23. Godwin KA., Sibbald B., Bedard T et al. Changes in Frequencies of Select Congenital Anomalies since the Onset of Folic Acid Fortification in a Canadian Birth Defect Registry. Can J Public Health. 2008;99(4):271-5.10.1007/BF03403753Search in Google Scholar